Saw palmetto
EMA Well-Established Use monograph for BPH symptoms, but the Cochrane review found no advantage over placebo.
- Evidence
- Preliminary evidenceGRADE certainty: Low
- Typical dose
- Hexanic extract: 320 mg/day single dose
- Time to effect
- Not established
- Safety
- Has documented cautions
Evidence ratings summarise published research on Saw palmetto in general. They are not a health claim for any product and not advice for any individual. Talk to your doctor before starting anything new, especially if you take medication.
Ask about Saw palmetto
Interactions
Taking any medication?
Check Saw palmetto against it.
Why
Saw palmetto (Serenoa repens) berry extract holds an EMA HMPC monograph at the Well-Established Use level for relief of lower urinary tract symptoms related to benign prostatic hyperplasia. The Cochrane review, however, found it was not superior to placebo for urinary symptom scores in two high-quality long-term trials (n=582), and a 72-week trial found no advantage even at double and triple doses. The regulatory assessment and the trial evidence point in opposite directions.
How it works
Inhibits 5α-reductase (the enzyme that converts testosterone to dihydrotestosterone), modulates androgen receptor signalling, and has anti-inflammatory effects in prostatic tissue.
Expected onset · Not established; the long-term trials found no advantage over placebo
How to take
Dosage
Hexanic extract: 320 mg/day single dose. Standard liposterolic extract: 160 mg twice daily.
Timing
Once daily with main meal
On the label
'Hexanic lipidosterolic extract' is the most-studied form. Generic ethanolic or CO2 extracts have inconsistent trial results.
Studied in
Adult men with mild-to-moderate lower urinary tract symptoms attributable to BPH, after specialist evaluation has excluded prostate cancer.
Safety
Evidence
Tacklind 2012 Cochrane Database Syst Rev meta-analysis: in two high-quality long-term trials (n=582), saw palmetto extract was not superior to placebo for urinary symptom scores in men with benign prostatic hyperplasia, and a 72-week trial found no advantage at double or triple doses. The EMA nonetheless lists a saw palmetto fruit monograph with well-established use status, so the evidence is mixed.
GRADE certainty: Low — rated by Healicus using the GRADE method
Questions people ask
Does Saw palmetto work?
Tacklind 2012 Cochrane Database Syst Rev meta-analysis: in two high-quality long-term trials (n=582), saw palmetto extract was not superior to placebo for urinary symptom scores in men with benign prostatic hyperplasia, and a 72-week trial found no advantage at double or triple doses. The EMA nonetheless lists a saw palmetto fruit monograph with well-established use status, so the evidence is mixed. Certainty of the evidence: Low, rated by Healicus using the GRADE method.
How is Saw palmetto taken?
Hexanic extract: 320 mg/day single dose. Standard liposterolic extract: 160 mg twice daily. Timing: Once daily with main meal. Ranges are those reported in the cited sources, not individual advice; talk to your doctor or pharmacist before starting, especially if you take medication.
Are there interactions or cautions?
Should follow specialist evaluation (PSA, DRE, symptom score) to exclude malignancy. Mild antiplatelet effect. Stop 2 weeks before surgery. May lower PSA modestly, complicating interpretation. Caution with anticoagulants and hormonal therapy. Pregnancy and women: not indicated. Mild GI upset and headache are the most common adverse events. Documented drug and supplement interactions can be looked up in the free interaction reference.
What is the evidence based on?
Sources: EMA HMPC monograph, Serenoa repens (Bartram) Small, fructus (Well-Established Use); Tacklind et al., Cochrane Database Syst Rev 2012, Serenoa repens for benign prostatic hyperplasia.
One evidence finding a day, like this one: follow Healicus on Threads or Bluesky.